Biography

Andrew Z. Wang, M.D., Professor, holds the A. Kenneth Pye Professor in Cancer Research and is the Associate Vice Chair for Translational Research.

Dr. Wang earned two bachelor of science degrees in biochemistry and biology and a bachelor of arts degree from Indiana University with highest distinction. He obtained his medical degree from the Harvard-MIT Health Sciences and Technology (HST) program at Harvard Medical School. After an internship in internal medicine at St. Luke’s Roosevelt Hospital in New York, he completed clinical training in radiation oncology in the Harvard Radiation Oncology Program. During residency, he also completed a postdoctoral fellowship in nanomedicine at Massachusetts Institutes of Technology under the mentorship of Dr. Robert Langer. Following residency, Dr. Wang joined the faculty of University of North Carolina as Assistant Professor in the Department of Radiation Oncology in 2009.

Dr. Wang’s research program is focused on the application of biomedical engineering to cancer research. His group aims to develop novel cancer diagnostics and therapeutics to improve cancer treatment. His work is highly innovative and has resulted in 15 patents/patent applications and two biotechnology startup companies. Because of his research accomplishments, Dr. Wang has been elected as a member of the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows and the American Society for Clinical Investigation (ASCI).

Clinically, Dr. Wang specializes in the treatment of genitourinary and gastrointestinal cancers. He is familiar with different radiation techniques, including IMRT, IGRT, linac-based SRS, SBRT, and intraoperative radiotherapy and interstitial brachytherapy.

Education

Medical School
Harvard Medical School (2004)
Internship
Columbia University/St. Luke's - Roosevelt Hospital Center (2005), Internal Medicine
Residency
Harvard/Brigham and Women's Hospital/Massachusetts General Hospital (2009)

Research Interest

  • Application of biomedical engineering to cancer research
  • Developing novel cancer diagnostics and therapeutics to improve cancer treatment

Honors & Awards

  • America's Top Doctors by Castle Connolly
    (2020)
  • American Institute for Medical and Biological Engineering (AIMBE) College of Fellows
  • ASCO Leadership Development Program
  • Associate Scientific Advisor, Science Translational Medicine
  • ASTRO Biology Basic Science Research Abstract Award
  • ASTRO Junior Faculty Basic Science Research Abstract Award
  • ASTRO Resident Poster Recognition Biology Award (Biology)
  • ASTRO Translational Research Meeting Travel Grant
  • Betty and Doris Barrett Scholarship, Harvard Medical School
  • Elected Member of the American Society for Clinical Investigation (ASCI)
  • Howard Hughes Medical Institute Research Fellowship for Medical Students
  • UNC Health Care and Faculty Physicians Award for Carolina Care Excellence

Professional Associations/Affiliations

  • BMC Cancer, Associate Editor (2018)
  • Journal of the National Cancer Institute, Member, Editorial Board (2017)
  • Nanomedicine: Nanotechnology, Biology, and Medicine, Associate Editor (2015)
  • American Society of Clinical Oncology (ASCO) (2009)
  • American Association for Cancer Research (AACR) (2007)
  • American Society for Radiation Oncology (ASTRO) (2006)